Christopher Talgo
Chris Talgo is editor & research fellow with The Heartland Institute
Chris Talgo joined The Heartland Institute in August 2017. He edits a variety of Heartland’s publications, including newsletters, op-eds, reports, and Research & Commentaries. Talgo writes op-eds, articles for Health Care News and Environmental and Climate News, and hosts podcasts.
Prior to working at The Heartland Institute, Talgo taught U.S. history and American government for five years in Bluffton, South Carolina. He served on the Town of Bluffton Accommodations Tax Committee and was elected precinct delegate for his voting district. He is an avid reader of history and social science. He enjoys watching and playing sports and competes in 5k and 10k runs.
Recent Articles and Publications
view all by this author
April 15, 2020
Due to coronavirus, governments across the globe are considering and/or are doing something they certainly could not do before: implement mass surveillance programs to track COVID-19 patients.
April 14, 2020
If the COVID-19 crisis has taught us one thing—aside from the need to wash your hands often—it is that the FDA's approval process for much-needed medicine to those with debilitating and terminal diseases is in dire need of reform.
March 5, 2020
In its first decade, ObamaCare has failed to solve many of the health care problems it was supposed to address.
February 11, 2020
Bravo to AOC and others who dare defy party bigwigs — those in smoke-filled rooms who make the “big” decisions and pull the political strings from afar.
February 1, 2020
This booklet seeks to establish, beyond any doubt, that Denmark, Norway, and Sweden have not embraced Marxist principles throughout much of their economies and are thus not “socialist” nations.
December 6, 2019
This paper seeks to establish, beyond any doubt, that Denmark, Norway, and Sweden have not embraced Marxist principles throughout much of their economies and are thus not “socialist” nations.
April 29, 2019
A new report estimates a single-payer health care system in the United States would cost between $54.6 and $60.7 trillion over the first 10 years.
